Scientists test TB vaccine safety with controlled exposure
NCT ID NCT06845358
Summary
This early-stage study aimed to test the safety of the BCG tuberculosis vaccine in healthy adults. Researchers planned to give some participants the vaccine and then expose all participants to a weakened TB strain six months later to measure immune responses. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.